Biogen Idec, Eisai to partner in RTP

Biogen Idec will be using Research Triangle Park facilities of Eisai Inc., the U.S. pharmaceutical business of a Japanese company, to make oral, solid dose products such as tablets through a partnership announced Wednesday.